Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?
نویسندگان
چکیده
Cornelia L Trimble1, Patti Gravitt2 & Richard BS Roden3† †Author for correspondence 1Johns Hopkins University, Departments of Gynecology and Obstetrics, Oncology, Pathology, 255 Phipps Building, Obstetrics Gynecology, 600 North Wolfe St, Baltimore, MD 21287, USA Tel.: +1 410 502 0512 Fax: +1 410 502 0621 [email protected] 2Departments of Epidemiology and Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E6535, Baltimore, MD 21231, USA Tel.: +1 443 287 6179 Fax: +1 410 955 1383 [email protected] 3Johns Hopkins University, Departments of Gynecology and Obstetrics, Oncology, Pathology, Room 308, CRB2, 1550 Orleans St, Baltimore, MD 21231 USA Tel.: +1 410 502 5161 Fax: +1 443 287 4293 [email protected]
منابع مشابه
Construction a DNA Vaccine Containing Human Papillomavirus Type 16 Early Genes as a Potential Vaccine for Cervical Cancer Prevention and Therapy
Background and Objectives: Some of the human papillomaviruses (HPVs) can infect genital tracts and are sometimes associated with anogenital tract cancers. HPVs induced cervical cancers through the expression of E6 and E7 genes by inactivating the tumor suppressor proteins. In this study, E6 and E7 genes were chosen in order to construct an expression vector which is able to express ...
متن کاملCytotoxic T-Cell Markers and Cytokines in Human Papillomavirus 16
Background and Aim: Cervical cancer is the fourth main cause of mortality among women, and annually about half a million new cases are detected in developed countries. Based on oncological studies, human papillomavirus (HPV) is classified into two categories: high-risk type and low-risk type, and most cases are related to the high-risk type of human papillomavirus. HPV 16 and 18 are among the m...
متن کاملPnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملپیشگیری ،HPV ،سرطان سرویکس، واکسیناسیون
Cervical cancer is the second most common gynecologic cancer. A steady 70% annual decline in mortality from cervical cancers has been observed since the mid 20th century after the introduction of widespread papanicolaou cytological screening. But also cervical cancer continues to be an important world health problem for women. Cervical cancer is one of the best- understood neoplasm given its we...
متن کاملPreventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
Cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. More than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (HPVs) particularly HPV types 16 and 18. Two major strategies have been developed forprevention and treatment of cervical cancer and other HPV-associated malignancies; the first one is based ...
متن کاملCervical cancer prevention & the role of human papillomavirus vaccines in India.
Human papillomavirus (HPV) is a necessary cause of cervical cancer, the leading cause of cancer deaths among Indian women. Current screening and prevention programs based on cytology have not been effective in reducing the disease burden. Two vaccines are now available for primary prevention. They generate neutralizing antibodies to HPV capsid protein. The vaccines have been shown to confer nea...
متن کامل